Temporary Pharmacy Programs

The Australian Government may, from time to time, introduce temporary programs to address specific needs in the community. These programs may not be funded under the Seventh Community Pharmacy Agreement (7CPA).

Page last updated: 06 May 2022

COVID-19 Home Medicines Service

The COVID-19 Home Medicines Service is available for people in home isolation and vulnerable people who wish to limit their potential exposure to the COVID-19 virus in the community. Under the Home Medicines Service, medicines can be delivered free of charge from pharmacies to eligible peoples’ homes as long as the delivery includes at least one Pharmaceutical Benefits Scheme or Repatriation Pharmaceutical Benefits Scheme medicine.

On Thursday 16 December 2021, it was announced in the Mid Year Economic Fiscal Outlook for 2021-22, that as part of the Australian Government’s continued investment in the national COVID-19 health response and to continue to protect the community while vaccinations continue across the country, the temporary COVID-19 Home Medicines Service (COVID-19 HMS) will be extended until 30 June 2022.

Under this extension the eligibility for the COVID-19 HMS program will be reset to the evolving pandemic situation from 1 February 2022. The service will be available to those people:
  • Directed to quarantine or isolate under public health orders, because they are either:
    • COVID-positive; or
    • A close contact of a COVID-positive patient; or
    • Receiving COVID treatment; or
  • Immunocompromised.

Data for this program is currently provided on a monthly basis:

Home Medicines Service Data (PDF 395 KB)
Home Medicines Service Data (Excel 10 KB)

Further information for consumers on the Home Medicines Service is available through the COVID-19 National Health Plan.

Further information on the program rules for the Home Medicines Service is available at the Pharmacy Programs Administrator website.